May 22, 2007
Cytyc back in line with market rules
By Matthew L. Brown
Cytyc Corp., a Marlboro-based medical device company, said it is in compliance with Nasdaq rules after filing its first-quarter report.
Nasdaq warned the company last week that it could be de-listed because its quarterly report had not been filed.
Cytyc said Nasdaq notified the company Monday that it is in compliance, and the matter is closed.
Cytyc filed its quarterly report last Friday.
Nasdaq warned the company last week that it could be de-listed because its quarterly report had not been filed.
Cytyc said Nasdaq notified the company Monday that it is in compliance, and the matter is closed.
Cytyc filed its quarterly report last Friday.
WBJ Web Partners
Most Recent
Most Recent
0 Comments